Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Prostatectomy Patient Outcomes Affected by Surgeon's Total Case Load

By HospiMedica International staff writers
Posted on 22 Feb 2010
A new study suggests that prostate cancer patients treated by more experienced urologic surgeons with higher volumes of surgery achieve improved results.

Researchers at the Memorial Sloan-Kettering Cancer Center (New York, NY, USA) analyzed data from the 2005 U.S. More...
Nationwide Inpatient Sample and a complete record of all hospital discharges in New York State (USA) to determine typical annual radical prostatectomy caseloads of surgeons in the United States. The results show that a surgeon needs to have completed a minimum of 250 prostatectomies to reach the "learning curve plateau,” at which point cancer cure is maximized and surgical complications minimized. After adjusting for tumor severity, a typical patient treated by a surgeon who has reached the learning curve plateau had a 10.9% risk of recurrence at 5 years, compared to 17.7% for those treated by a less experienced surgeon. Similarly, surgical complications were decreased by 20% in patients treated by the highest versus the lowest volume surgeons studied.

Furthermore, for the 75% of patients diagnosed with cancers still confined to the prostate gland, the most highly experienced surgeons--who had performed at least 1,500 prior surgeries--achieved recurrence rates of less than 1%, suggesting that recurrence is largely dependent on surgical technique. Despite these findings, the researchers found that approximately 25% of U.S. surgeons performed only a single radical prostatectomy procedure per year, while about 80% of the surgeons performed fewer than 10 procedures per year. In all, according to the study, only 1.8% of surgeons in the United States perform more than 50 prostatectomies per year, and most surgeons will never reach the key threshold of 250 radical prostatectomy cases during their surgical careers. The study was published in the December 2009 issue of the Journal of Urology.

"The current pattern of surgical treatment for prostate cancer leads to many patients being treated by surgeons with low annual caseloads, with likely poorer outcomes as a result,” concluded study authors Caroline Savage, B.A., and Andrew Vickers, Ph.D., of the department of epidemiology and biostatistics.

"Practice patterns in which the majority of prostate cancers patients undergoing surgery are treated by surgeons performing fewer than 10 procedures a year suggest that better results may be achievable for many of these men,” commented Kevin Slawin, M.D., director of urology at Memorial Hermann-Texas Medical Center (Houston, USA). "The study provided data that supports what common sense suggests - that a more experienced surgeon will likely produce more positive results for patients undergoing a procedure as technically complex and challenging as radical prostatectomy.”

Related Links:

Memorial Sloan-Kettering Cancer Center
Memorial Hermann-Texas Medical Center




Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
X-Ray Generator
Advantage Plus Generators
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.